MFS
BEAM icon

Mirabella Financial Services’s Beam Therapeutics BEAM Stock Holding History

Mirabella Financial Services’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-21,693
Closed -$534K – 326
2020
Q3 		$534K Buy
+21,693
New +$538K 0.07% 132

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Mirabella Financial Services's BEAM Position: Q4 2020 in Review

Mirabella Financial Services sold out of Beam Therapeutics (BEAM) in Q4 2020, closing a stake of 21,693 shares — an estimated $534K sold.

Mirabella Financial Services first reported a position in BEAM in Q3 2020 and held it in 1 quarter. The position peaked at $534K in Q3 2020. 158 funds tracked by Wall St. Rank hold BEAM as of Q4 2020.

  • Mirabella Financial Services reported no remaining Beam Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Mirabella Financial Services sold 21,693 Beam Therapeutics shares in Q4 2020, an estimated $534K.
  • Mirabella Financial Services first reported a position in Beam Therapeutics in Q3 2020 and held it in 1 quarter.
  • Mirabella Financial Services's Beam Therapeutics position peaked at $534K in Q3 2020.
  • 158 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2020.

Based on Mirabella Financial Services's 13F filing for Q4 2020, filed 16 Feb 2021.